TEVA-SITAGLIPTIN MALATE

Identification of Teva-Sitagliptin Malate

No description

Google image searchProduct monograph

Active ingredient

sitagliptin (sitagliptin malate), 25 MG

DIN: 02522705

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 31-AUG-2023

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
• A10BH — Dipeptidyl peptidase 4 (DPP-4) inhibitors (ATC, ATC/DDD)
• A10BH01 — SITAGLIPTIN (ATC/DDD)

Reference brand drug: Januvia

External Links for Teva-Sitagliptin Malate

Search on Google

• Teva-Sitagliptin Malate side effects
• Teva-Sitagliptin Malate dosage
• sitagliptin side effects
• sitagliptin dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-sitagliptin malate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.